NANCY BUCKNER: Open Payments
NPI 1467413369 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 7 payments from 4 companies in 2025. Trend: 2023 $202 · 2024 $143 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Noven Therapeutics, LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: CAPLYTA, REXULTI, Xelstrym, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
